Phototherapy Treatment - Global Strategic Business Report

The global market for Phototherapy Treatment was valued at US$1.7 Billion in 2025 and is projected to reach US$2.2 Billion by 2032, growing at a CAGR of 3.7% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Phototherapy Treatment Market - Key Trends & Drivers Summarized

Why Is Phototherapy Becoming a Mainstay in the Treatment of Dermatological and Neonatal Conditions?

Phototherapy, the medical application of specific wavelengths of light to treat physiological or dermatological disorders, has become an essential modality in modern clinical practice. Widely used to manage chronic skin diseases such as psoriasis, vitiligo, eczema, and acne, as well as neonatal jaundice, phototherapy offers a non-invasive, drug-free option that modulates immune response, promotes cellular regeneration, and reduces inflammation. The controlled exposure to ultraviolet A (UVA), UVB, or narrowband UVB light can normalize skin cell growth and stimulate repigmentation, making it effective in both hospital and outpatient settings.

In neonatal care, blue light phototherapy remains the gold standard for treating hyperbilirubinemia by converting unconjugated bilirubin into water-soluble isomers for easier excretion. This life-saving intervention has reduced the incidence of kernicterus and long-term neurological damage in newborns worldwide. With the increasing prevalence of skin conditions and rising awareness of the side effects associated with long-term steroid or systemic drug use, phototherapy is increasingly being preferred by both clinicians and patients seeking long-term, relapse-controlled management.

How Are Device Innovation and Treatment Personalization Enhancing Phototherapy Outcomes and Safety?

Technological advances in phototherapy devices have significantly improved treatment precision, safety, and patient adherence. Modern devices offer programmable UV dosage, skin-type calibration, real-time temperature monitoring, and targeted beam delivery, which minimizes overexposure and maximizes therapeutic impact. Narrowband UVB (NB-UVB) devices are now widely adopted for their ability to deliver effective treatment at lower carcinogenic risk compared to broadband UV systems. Handheld and comb devices allow for precision treatment in localized areas such as the scalp, hands, or feet.

At-home phototherapy units, backed by physician oversight and app-based compliance monitoring, are gaining popularity among patients with chronic dermatologic conditions. These devices reduce the logistical burden of frequent clinic visits, while ensuring consistent dosing protocols. Wearable light patches and LEDs tuned to specific therapeutic wavelengths are being developed for low-dose, continuous treatment with minimal disruption to daily life. Advances in photodosimetry, AI-assisted treatment planning, and skin phototype analysis are enabling personalized regimens that improve outcomes and reduce phototoxicity risks.

Which Patient Populations and Therapeutic Areas Are Driving Phototherapy Adoption Globally?

Patients with autoimmune skin diseases - such as psoriasis, vitiligo, and atopic dermatitis - represent the largest beneficiary group for phototherapy, especially when systemic medications are contraindicated or have failed. Acne patients and those with cutaneous T-cell lymphoma or polymorphic light eruption also rely on phototherapy for sustained remission. In neonatal care, phototherapy remains integral to pediatric units, particularly in resource-constrained settings where alternative treatments are limited. Additionally, mental health research is exploring phototherapy for seasonal affective disorder (SAD) and circadian rhythm regulation.

North America and Europe lead in phototherapy infrastructure and dermatology specialization, with well-established treatment protocols and insurance coverage in many jurisdictions. Asia-Pacific is seeing rapid uptake due to high incidence of vitiligo and psoriasis, growing access to dermatological care, and expanding neonatal health initiatives. In emerging economies, mobile phototherapy units and NGO-supported equipment donations are improving access in rural clinics. Rising public health focus on skin disease burden is further driving awareness, early diagnosis, and treatment accessibility across diverse geographies.

What Is Fueling Long-Term Growth and Strategic Innovation in the Phototherapy Market?

The growth in the phototherapy treatment market is driven by the rising incidence of dermatological conditions, a shift toward non-pharmacological therapies, and increasing awareness of skin health and neonatal care. With growing concerns around the long-term side effects of immunosuppressants and antibiotics, phototherapy is gaining ground as a safe, cost-effective, and repeatable treatment modality. The expansion of teledermatology and home-based care models is further accelerating patient adoption and treatment continuity.

Strategically, companies are investing in compact, AI-guided phototherapy systems with smart connectivity and adaptive dosage controls. Partnerships with dermatology clinics, hospitals, and maternal health networks are enabling large-scale deployment of both fixed and mobile units. Clinical trials investigating new wavelength combinations, photobiomodulation for wound healing, and dual-modality therapy (e.g., light + biologics) are expanding the therapeutic envelope of phototherapy. As regulatory frameworks evolve to support home-based medical technologies, phototherapy is poised to become a foundational tool in chronic disease management and personalized medicine.

Report Scope

The report analyzes the Phototherapy Treatment market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:

• Segments: Disease Type (Psoriasis Disease Type, Acne Disease Type); Phototherapy Type (Blue Light Phototherapy, Red Light Phototherapy, Intense Pulsed Light Phototherapy, Other Phototherapy Types); End-Use (Hospitals End-Use, Dermatology Clinics End-Use, Homecare Settings End-Use, Other End-Uses).
• Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Psoriasis Disease Type segment, which is expected to reach US$1.5 Billion by 2032 with a CAGR of a 3.2%. The Acne Disease Type segment is also set to grow at 4.9% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $528.3 Million in 2025, and China, forecasted to grow at an impressive 6.8% CAGR to reach $515.2 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Phototherapy Treatment Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Phototherapy Treatment Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Phototherapy Treatment Market expected to evolve by 2032?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2032?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Atom Medical Corporation, Daavlin, Dermalux, GE Healthcare, Herbert Waldmann GmbH & Co. KG and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Phototherapy Treatment market report include:

• Atom Medical Corporation
• Daavlin
• Dermalux
• GE Healthcare
• Herbert Waldmann GmbH & Co. KG
• Hill-Rom
• Ibis Medical Equipment and Systems Pvt. Ltd.
• LumiThera
• Medela AG
• MTTS
• MuReva Phototherapy
• National Biological Corporation
• Natus Medical Incorporated
• NeoMedLight
• Nice Neotech Medical Systems Pvt. Ltd.
• Ningbo David Medical Device Co., Ltd.
• Phoenix Medical Systems Pvt. Ltd.
• Phothera
• Solarc Systems Inc.
• Tiny Hearts Technology

What Sets This Report Apart From Others?

• Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
• Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
• Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
• Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
• Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
• Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, our reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.